Sodium ion homeostasis in myocardial tissue

Sodium ion homeostasis in myocardial tissue refers to the precise regulation of sodium concentrations within cardiac myocytes, which is essential for maintaining the resting membrane potential and supporting the cardiac action potential (StatPearls, 2023). This homeostatic process is primarily mediated by the Sodium-potassium-activated adenosine triphosphatase (Na+/K+-ATPase), which actively transports sodium out of the cell, and the sodium-calcium exchanger (NCX), which facilitates sodium-dependent calcium transport (UniProt, 2024; NCBI, 2022). Additionally, voltage-gated sodium channels like Nav1.5 are critical for the rapid influx of sodium during depolarization (UniProt, 2024). Disruptions in this balance, such as intracellular sodium overload, are central to the pathophysiology of heart failure and various arrhythmias, leading to impaired relaxation and increased risk of sudden cardiac death (PubMed, 2021). Therapeutic interventions often target specific components of this system; for example, cardiac glycosides like digoxin inhibit the Na+/K+ pump to enhance contractility, while ranolazine targets the late sodium current to alleviate ischemia-related sodium overload (FDA, 2020; PubMed, 2019).

Other names

Cardiac sodium regulationMyocardial sodium balanceIntracellular sodium homeostasisCardiac sodium handling

Pharmacological agents modulate sodium homeostasis by inhibiting the Na+/K+-ATPase pump to increase intracellular calcium and contractility (e.g., digoxin), blocking voltage-gated sodium channels to stabilize rhythm (e.g., lidocaine), or selectively inhibiting the late sodium current to reduce sodium-dependent calcium overload (e.g., ranolazine) (StatPearls, 2023; FDA, 2020).